Skip to main content

Table 1 Characteristics of cystic fibrosis study population receiving tobramycin inhalation solution, N = 804.

From: Adherence with tobramycin inhaled solution and health care utilization

Demographic characteristics %*
Age, years  
   <6** 13.2
   6-10 12.2
   11-17 31.5
   18-25 22.0
   ≥26 21.1
Gender  
   Male 52.7
   Female 47.3
Comorbidity score  
   ≤Average 65.3
   >Average 34.7
Geographic region  
   Northeast 12.3
   Midwest 27.0
   South 39.1
   West 21.4
Health Plan Type  
   Comprehensive 7.6
   HMO 23.0
   Preferred Provider Organization 49.0
   Other Plans 20.4
Selected comorbidity  
   Pseudomonas aeruginosa 56.1
   Failure to thrive/Growth failure 4.4
  1. *percentages may not add up to 100% due to rounding
  2. **< 6 years of age further divided; 3.9% of patients were < 2 years of age and 9.3% were 2-5 years of age.